PBM Transparency Included In Democrats’ Drug Pricing Deal

By Gabrielle Wanneh / November 9, 2021 at 4:37 PM
Democrats’ drug pricing deal bars pharmacy benefit managers from entering into contracts with drug makers that limit the disclosure of information to health plan sponsors, among other reporting requirements. The text does not, however, include provisions for combating spread pricing, drug rebates or pharmacy price concessions. After initially excluding government drug price controls from their reconciliation bill, Democrats reinserted policies to let Medicare negotiate drug prices in limited circumstances and make drug companies pay back Medicare when they raise prices...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.